Drug · DIN 02419149
BOSULIF
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since April 24, 2014; first marketed April 24, 2014.
- Drug Identification Number (DIN)
- 02419149
- Company (DIN owner)
- Pfizer Canada UlcKirkland, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Bosutinib L01EA04
- Class
- Human
- Record last updated
- July 3, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| BOSUTINIB (BOSUTINIB MONOHYDRATE) | 100 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- March 7, 2014: NOC 15380New Drug Submission (NDS)
Other DINs named BOSULIF
- DIN 02419157 · Marketed
- DIN 02483793 · Cancelled Pre Market